Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-16

Clinical Trial Update: The Effect of Mankai on Glycemic Control Among Patients With T2D [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of Mankai on glycemic control in adults with Type 2 diabetes; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mankai

Snippet

Sponsor: Ben-Gurion University of the Negev | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: ACTIVE_NOT_RECRUITING